ELAN - שווי פעילות Elanco Animal Health

This chart illustrates the market price of Elanco Animal Health (ELAN), which has an enterprise value of 14704.44, reflecting a business focused on developing veterinary products. The company's growth relies on launching breakthrough medications for pets, reducing debt, and implementing Bovaer to reduce methane emissions. High barriers to entry are driven by massive R&D expenditures and strict FDA oversight, while system stability is ensured by farmer loyalty to vaccines.

When selecting defensive assets, the priority becomes capital resilience against debt loads and market volatility. For Elanco Animal Health (ELAN), whose revenue depends on livestock populations and veterinary drug regulations, the enterprise value sums market capitalization and net debt, determining the real acquisition price of the business and allowing the investor to distinguish fundamental undervaluation from bankruptcy risk.